Skip to main content
Caplight Logo









Pinnacle Transplant Technologies

Pinnacle Transplant Technologies

Private
Phoenix, ArizonaHealthcare & Life Scienceshttps://pinnacletransplant.com/

Last Round

Seed

Apr 9, 2015

Total Funding Raised

$2.48M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Pinnacle Transplant Technologies is a healthcare company that processes and distributes high-quality allograft implants for use in spine, sports medicine, orthopedics, trauma, dental, and wound care procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

allograft implantstissue bankcontract manufacturingOEM servicesbone graftsregenerative medicineamniotic membraneprivate labelingmedical device manufacturingorthopedic implantsbiologicstissue processingsports medicine implantswound care productsAATB accreditation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pinnacle Transplant Technologies Comparables

Compare Pinnacle Transplant Technologies with similar companies based on industry and business-model similarity.

Pinnacle Transplant Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VIVEX Biologics
85%
Skye Biologics Holdings
83%
AlloSource
81%

Pinnacle Transplant Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 9, 2015
GrantMar 7, 2014

Key People

Founding team and executive leadership

Gabriel Hyams

Chairperson of the Board, Chairman of the Board & Majority Shareholder (2020 Present) Founder & President CEO (2010 2020)

Founding Team

Roger Rose

President and Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 141% MoM.

  • Mar 3, 2026

    Monthly visitors grew 57% MoM, reaching 1.4K.

Pinnacle Transplant Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pinnacle Transplant Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pinnacle Transplant Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhoenix, Arizona
Employee Range111
Year Founded2010
Last FundingApr 9, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?